In the News…
When a tyrosine kinase inhibitor for the abl oncogene protein hit the market, it had a dramatic effect on survival. Now alternative drugs have been developed, but the price of the original pill has not gone down. In the face of competition, how come?
How much would YOU pay for a drug that cures ...
Early onset Alzheimer Disease (AD) is caused by gene mutations that lead to abnormal processing of amyloid precursor protein (APP). A chromosome 21 mutation leads to the formation of abnormal amyloid precursor protein (APP). Presenilin genes on chromosomes 1 and 14 encode proteins that play a role in APP breakdown, and can also lead […]
Genetic Tests for Alzheimer Disease: Do you want to know?
An interesting Radiolab was presented today on the growing field of synthetic biology and genetic bioengineering. The broadcast raised the issue of the ever-increasing promise and benefits that can be obtained from the application of the technology…as well as potential ethical and weaponizing pitfalls. The broadcast can be accessed from […]
